MedPath

To find the relation between various blood parameters and functioning of heart in ST elevation myocardial infarction patients.

Not yet recruiting
Conditions
ST elevation (STEMI) myocardial infarction of unspecified site,
Registration Number
CTRI/2023/09/057902
Lead Sponsor
GGSMCH FARIDKOT
Brief Summary

India has the highest burden of Acute Coronary Syndrome (ACS) patients in the world. Indian Patients who suffer from ACS are relatively younger and have a  significantly higher proportion  of ST-elevation myocardial infarction (STEMI) as compared to patients in developed countries. It is estimated that more than 3 million STEMI occurs every year in India. The measurement of left ventricular ejection fraction (LVEF) after acute myocardial infarction (AMI) is a class I clinical practice guideline recommendation, and  has both prognostic and therapeutic implications. Reduced LVEF is associated with greater mortality in patients with coronary artery disease and predicts increased risks of early mortality, as well as sudden cardiac death. Serum ferritin is an acute phase reactant and is considered to be a risk factor for MI. High serum ferritin may increase the risk of MI in the presence of other risk factors that increase the formation of free radicals, thus accelerating atherogenesis through stimulation of low-density lipoprotein oxidation. So, the aim of the study is to find the correlation of troponin I and ferritin levels with left ventricular ejection fraction in ST elevation MI patients presenting to the hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 1.Acute onset MI as diagnosed by typical clinical presentation.
  • ECG characteristics specific of STEMI.
Exclusion Criteria
  • 1.Previous history of myocardial infarction.
  • 2.A patient having pre existing ECG changes s/o old MI or ECG showing Q wave at the time of admission.
  • LVH, conduction defects, heart blocks.
  • Conditions in which Troponin I levels increases irrespective of heart disease.: renal impairment, rheumatoid arthritis, pericarditis, spesis, acute congestive heart failure, acute pulmonary embolism, or prolonged tachyarrythmias.
  • Hemochromatosis, liver disease, TB, patients on iron supplements.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Troponin I levelsbaseline
S. ferritin levelsbaseline
Left ventricular ejection fractionbaseline
Secondary Outcome Measures
NameTimeMethod
Correlation OF S. ferritin & troponin I levels along with their correlation with left ventricular ejection fractionbaseline

Trial Locations

Locations (1)

Guru Gobind Singh Medical College and Hospital, Faridkot.

🇮🇳

Faridkot, PUNJAB, India

Guru Gobind Singh Medical College and Hospital, Faridkot.
🇮🇳Faridkot, PUNJAB, India
Dr Lovish Batheja
Principal investigator
7777800027
lovishbatheja@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.